Tony Kouzarides
{{BLP sources|date=March 2025}}
{{EngvarB|date=August 2017}}
{{Use dmy dates|date=August 2017}}
{{Infobox scientist
| honorific_prefix = Sir
| name = Tony Kouzarides
| image = Kouzarides Tony 2024.jpg
| image_size =
| alt =
| caption =
| birth_date = {{Birth date and age|df=yes|1958|1|17}}{{cite web|url=http://www.ukwhoswho.com/view/article/oupww/whoswho/U4000174|title=KOUZARIDES, Prof. Tony|work=Who's Who 2013, A & C Black, an imprint of Bloomsbury Publishing plc, 2013; online edn, Oxford University Press|access-date=2015-03-18}} {{subscription required}}
| birth_place =
| death_date =
| death_place =
| nationality =
| fields = Cancer
Chromatin
Transcription
| workplaces = University of Leeds
University of Cambridge
Gurdon Institute
New York University
Laboratory of Molecular Biology
Abcam
| alma_mater = University of Leeds (BSc)
University of Cambridge (PhD)
| thesis_title = A molecular analysis of transformation by human cytomegalovirus
| thesis_url = http://ulmss-newton.lib.cam.ac.uk/vwebv/holdingsInfo?bibId=10515
| thesis_year = 1985
| doctoral_advisor = Tony Minson{{Cite journal
| last1 = Cranage | first1 = M. P.
| last2 = Kouzarides | first2 = T.
| authorlink2=Tony Kouzarides
| last3 = Bankier | first3 = A. T.
| last4 = Satchwell | first4 = S.
| last5 = Weston | first5 = K.
| last6 = Tomlinson | first6 = P.
| last7 = Barrell | first7 = B.
| last8 = Hart | first8 = H.
| last9 = Bell | first9 = S. E.
| last10 = Minson | first10 = A. C.
| title = Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus
| journal = The EMBO Journal
| volume = 5
| issue = 11
| pages = 3057–3063
| year = 1986
| pmid = 3024973
| pmc = 1167261
| doi = 10.1002/j.1460-2075.1986.tb04606.x
}}
| academic_advisors =
| doctoral_students =
| awards = Heinrich Wieland Prize {{small|(2013)}}
Fellow of the Royal Society (2012){{cite web|url=http://royalsociety.org/people/tony-kouzarides|title=Professor Tony Kouzarides FMedSci FRS|access-date=2012-04-24}}
FMedSci (2001){{cite web|url=http://www.acmedsci.ac.uk/p59fid5445.html|title=The Academy of Medical Sciences | Directory of Fellows|archive-date=2015-04-03|url-status=dead|archive-url=https://web.archive.org/web/20150403170246/http://www.acmedsci.ac.uk/p59fid5445.html}}
| signature =
| signature_alt =
| website = {{URL|www.gurdon.cam.ac.uk/~kouzarideslab}}
{{URL|royalsociety.org/people/tony-kouzarides}}
| footnotes =
| spouse =
}}
Sir Tony Kouzarides (born 17 January 1958) is an English biologist who is a senior group leader at the Gurdon Institute,{{cite web|url=http://www.gurdon.cam.ac.uk/~kouzarideslab|title=The Kouzarides Lab at the Gurdon Institute|access-date=2012-04-24}} a founding non-executive director of Abcam{{cite web|url=http://www.abcamplc.com/directors.html |title=Abcam board of directors|access-date=2012-04-24}} and a Professor of Cancer Biology at the University of Cambridge.{{cite web|url=http://www.cancer.cam.ac.uk/directory/profile.php?tk106|title=Professor Tony Kouzarides profile- Cambridge Cancer Centre|archive-date=2013-09-13|url-status=dead|archive-url=https://archive.today/20130913011940/http://www.cancer.cam.ac.uk/directory/profile.php?tk106}}
Education
{{BLP unreferenced section|date=March 2025}}
Tony Kouzarides did his PhD at the University of Cambridge and his postdoctoral work at MRC Laboratory of Molecular Biology in Cambridge. After his studies, he joined NYU Medical Center in New York where he worked on the c-Fos oncoprotein and the characterization of the leucine zipper.
Research and activities
Kouzarides is Professor of Cancer Biology at the University of Cambridge and a group leader at the Gurdon Institute, a research institution focused on epigenetic modifications and their involvement in cancer. He is Director and Co-founder of the Milner Therapeutics Institute, director of Cambridge Gravity and director of STORM Therapeutics.{{citation needed|date=March 2025}}
Kouzarides is founder, patron and ex-director of a cancer charity in Spain called Conquer Cancer (Vencer el Cancer). He is on the Scientific Advisory Board of the Institute of Cancer Research (UK) and on the Executive Board of the CRUK Cambridge Cancer Centre. He is a co-founder and ex-director of Abcam plc, a publicly trading research reagents company in Cambridge, a co-founder and ex-director of Chroma Therapeutics, of a drug discovery company based in Oxford and a co-founder and current director of STORM Therapeutics, a drug discovery company based in Cambridge.
Awards and prizes
Kouzarides has been elected member of the European Molecular Biology Organization, Fellow of the British Academy of Medical Sciences] (FMedSci), Fellow of the Royal Society (FRS), Fellow of the American Academy of Arts and Sciences (AAAS) and is a Cancer Research UK Gibb Fellow. He has been awarded the Wellcome Trust medal for research in biochemistry related to medicine (UK), the Tenovus Medal (UK), the Bodossaki Foundation prize in Biology (Greece), the Bijvoet Medal (Holland), the Biochemical Society Award Novartis Medal and Prize (UK) and the Heinrich Wieland Prize (Germany).
He was knighted in the 2024 King's Birthday Honours "for services to healthcare innovation and delivery".{{London Gazette |issue= 64423 |date= 15 June 2024 |page= B2 |supp= y }}
References
{{reflist}}
{{FRS 2012}}
{{Authority control}}
{{DEFAULTSORT:Kouzarides, Tony}}
Category:Fellows of the Royal Society
Category:Members of the European Molecular Biology Organization
Category:Academics of the University of Cambridge
Category:English people of Greek descent
Category:Place of birth missing (living people)
Category:Bijvoet Medal recipients